Nautilus Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$312K Buy
701
+235
+50% +$105K 0.23% 122
2025
Q1
$226K Buy
+466
New +$226K 0.19% 140